MAPT and Alzheimer disease: These results demonstrate the multifaceted role of DAPK1 and the essential contribution of DAPK1-induced SENP1 dysregulation in regulating neuronal tau pathology, and provide potential candidate targets for the development of treatment strategies for AD.